Chronic Lymphocytic Leukemia — Trials

Chronic Lymphocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

1,256 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 265
Recruiting: 124
Ph III recruiting: 16
Growth YoY: −16.3%
Industry share: 33%
Top sponsor: City of Hope Medical Center
Termination share: 34.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (239)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00086580	Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients	completed	Phase 3	335	Genzyme, a Sanofi CompanyINDUSTRY	15	Mar 13, 2014	clinicaltrials
NCT00799461	Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications	completed	Phase 3	1,337	Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium